VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
NCT07104383
·
clinicaltrials.gov ↗
PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
1100
Enrollment
INDUSTRY
Sponsor class
Conditions
Weight Loss
Interventions
DRUG:
VK2735
Sponsor
Viking Therapeutics, Inc.